{"title":"Nanomedicine hitchhiking on bacteria for treating tumors (4/2024)","authors":"Shujing Zheng, Xingwei Li, Shutao Guo","doi":"10.1002/bmm2.12131","DOIUrl":null,"url":null,"abstract":"<p>Taking advantage of autonomous navigation and deep penetration capabilities of bacteria, the use of bacteria as carriers for nanomedicine has attracted significant attention. In the review (DOI: 10.1002/bmm2.12110), Shujing Zheng, Xingwei Li, and Shutao Guo have systematically summarized current strategies for integrating bacteria and nanomedicines through different administration routes, highlighting both the clinical progress and the challenges faced in bacterial-based anti-tumor therapies. They have provided a perspective on the future development of nanomedicine hitchhiking on bacteria for cancer treatment.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"2 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12131","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMEMat","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bmm2.12131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Taking advantage of autonomous navigation and deep penetration capabilities of bacteria, the use of bacteria as carriers for nanomedicine has attracted significant attention. In the review (DOI: 10.1002/bmm2.12110), Shujing Zheng, Xingwei Li, and Shutao Guo have systematically summarized current strategies for integrating bacteria and nanomedicines through different administration routes, highlighting both the clinical progress and the challenges faced in bacterial-based anti-tumor therapies. They have provided a perspective on the future development of nanomedicine hitchhiking on bacteria for cancer treatment.